M. Urowitz

发表

The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus.

D. Gladman, M. Urowitz, C. Goldsmith, 1997, Arthritis and rheumatism.

Mortality in systemic lupus erythematosus.

M. Urowitz, P. Fortin, E. Ginzler, 1987, Arthritis and rheumatism.

Erratum: Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort

M. Urowitz, J. Sánchez-Guerrero, S. Bae, 2016, Lupus Science & Medicine.

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort

I. Bruce, D. Gladman, M. Urowitz, 2016, Lupus Science & Medicine.

Impaired brachial artery endothelium dependent flow mediated dilation in systemic lupus erythematosus: preliminary observations

D. Gladman, M. Urowitz, M. Urowitz, 2004, Lupus.

Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment

M. Urowitz, E. Ginzler, O. Nived, 2018, Lupus.

Disease course patterns in systemic lupus erythematosus

M. Urowitz, K. Tselios, D. Gladman, 2018, Lupus.

Shrinking lung syndrome in systemic lupus erythematosus: a single-centre experience

D. Gladman, M. Urowitz, M. Urowitz, 2018, Lupus.

OP0254 A propensity score-matched (PSM) analysis of organ damage in patients with systemic lupus erythematosus (SLE) from the pooled bliss long-term extension (LTE) trials versus the toronto lupus cohort (TLC)

Anand A. Joshi, M. Urowitz, Y. Asukai, 2018, FRIDAY, 15 JUNE 2018.

Disease evolution in late-onset and early-onset systemic lupus erythematosus

D. Gladman, M. Urowitz, J. Su, 2017, Lupus.

Breast cancer in systemic lupus

M. Urowitz, E. Ginzler, C. Gordon, 2017, Lupus.

Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study

M. Urowitz, M. Urowitz, A. Drucker, 2016, Lupus.

Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity

D. Gladman, L. Magder, M. Urowitz, 2011, Lupus.

Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus

D. Gladman, M. Urowitz, J. Wither, 2008, Annals of the rheumatic diseases.

Association of killer cell immunoglobulin–like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus

M. Urowitz, V. Chandran, D. Ibañez, 2008, Lupus.

The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients

M. Urowitz, D. Ibañez, D. Gladman, 2007, Lupus.

Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus

M. Urowitz, D. Ibañez, D. Gladman, 2006, Lupus.

Race/ethnicity and cancer occurrence in systemic lupus erythematosus.

M. Urowitz, P. Fortin, E. Ginzler, 2005, Arthritis and rheumatism.

Anti-C1q antibodies in systemic lupus erythematosus

I. Bruce, A. Orbai, M. Urowitz, 2015, Lupus.

Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease

D. Gladman, M. Urowitz, M. Urowitz, 2009, Lupus.

Lung cancer in systemic lupus erythematosus

M. Urowitz, P. Fortin, E. Ginzler, 2012, Arthritis Research & Therapy.

Lung cancer in systemic lupus erythematosus.

D. Gladman, M. Urowitz, E. Ginzler, 2007, Lung cancer.

Azathioprine in early rheumatoid arthritis

M. Urowitz, T. Hunter, M. A. Ogryzlo, 1977 .

The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison.

D. Gladman, M. Urowitz, C. Goldsmith, 2000, The Journal of rheumatology.

Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus.

D. Gladman, M. Urowitz, C. Goldsmith, 1992, The Journal of rheumatology.

Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.

D. Gladman, M. Urowitz, R. Flower, 1994, The Journal of rheumatology.

CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.

M. Urowitz, M. Weinblatt, B. Hazleman, 1995, Arthritis and rheumatism.

67Gallium lung scans in progressive systemic sclerosis.

M. Urowitz, D. Feiglin, R. Hyland, 1983, Arthritis and rheumatism.

Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.

M. Urowitz, R. Hyland, M. Baron, 1982, British heart journal.

Pulmonary hypertension in systemic lupus

D. Gladman, M. Urowitz, J. Granton, 2004, Lupus.

Vitamin D insufficiency in a large female SLE cohort

M. Urowitz, D. Gladman, D. Cole, 2010, Lupus.

Nonlymphoma hematological malignancies in systemic lupus erythematosus

M. Urowitz, P. Fortin, E. Ginzler, 2012, Arthritis Research & Therapy.

Breast Cancer in Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, E. Ginzler, 2013, Oncology.

OP0020 Validation of new systemic lupus erythematosus classification criteria

M. Urowitz, X. Mariette, M. Aringer, 2018, WEDNESDAY, 13 JUNE 2018.

Prevalence and associated factors of low bone mass in adults with systemic lupus erythematosus

M. Urowitz, D. Gladman, J. Su, 2017, Lupus.

Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group.

D. Gladman, M. Urowitz, C. Goldsmith, 1996, The Journal of rheumatology.

Accelerated nodulosis during azathioprine therapy.

M. Urowitz, P. Langevitz, L. Maguire, 1991, Arthritis and rheumatism.

The Effect of Lupus Nephritis on Pregnancy Outcome and Fetal and Maternal Complications

D. Gladman, M. Urowitz, M. Urowitz, 2010, The Journal of Rheumatology.

Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors

D. Gladman, M. Urowitz, M. Urowitz, 2018, Lupus.

Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus.

D. Gladman, M. Urowitz, M. Urowitz, 2001, The Journal of rheumatology.

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

D. Symmons, D. Gladman, M. Urowitz, 1996, Arthritis and rheumatism.

Prostaglandin E1 therapy for digital ulcers in scleroderma.

M. Urowitz, P. Madras, M. Baron, 1982, Canadian Medical Association journal.

Non-Hodgkin’s lymphoma in systemic lupus erythematosus

D. Gladman, M. Urowitz, E. Ginzler, 2005, Annals of the rheumatic diseases.

An international cohort study of cancer in systemic lupus erythematosus.

D. Gladman, M. Urowitz, E. Ginzler, 2005, Arthritis and rheumatism.

Variability and correlates of high sensitivity C-reactive protein in systemic lupus erythematosus

M. Urowitz, M. Nikpour, D. Gladman, 2009, Lupus.

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.

I. Bruce, D. Gladman, M. Urowitz, 2007, Arthritis and rheumatism.

Impaired antigen-specific suppressor cell activity in patients with systemic lupus erythematosus.

M. Urowitz, E. Keystone, L. Poplonski, 1980, Clinical and experimental immunology.

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case–cohort study

M. Urowitz, E. Ginzler, C. Gordon, 2007, Annals of the rheumatic diseases.

Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.

I. Bruce, D. Gladman, M. Urowitz, 2008, Arthritis and rheumatism.

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study.

I. Bruce, D. Gladman, M. Urowitz, 2008, Arthritis and rheumatism.

International consensus for a definition of disease flare in lupus

M. Urowitz, P. Fortin, C. Gordon, 2011, Lupus.

Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus

I. Bruce, M. Urowitz, E. Ginzler, 2014, Arthritis care & research.

SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus

I. Bruce, D. Gladman, M. Urowitz, 2011, Annals of the rheumatic diseases.

Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

C. Bombardier, D. Gladman, M. Urowitz, 1994, The Journal of rheumatology.

Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.

C. Bombardier, D. Gladman, M. Urowitz, 1992, The Journal of rheumatology.

Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort

I. Bruce, D. Gladman, M. Urowitz, 2012, Arthritis care & research.

Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus

E. Silverman, D. Gladman, M. Urowitz, 2008, Lupus.

Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?

D. Gladman, M. Urowitz, M. Urowitz, 2013, Lupus.

New therapies in systemic lupus erythematosus – trials, troubles and tribulations…. working towards a solution

M. Urowitz, C. Gordon, D. Isenberg, 2008, Lupus.

SLEDAI-2K for a 30-day window

M. Urowitz, D. Gladman, Z. Touma, 2010, Lupus.

D. Gladman, M. Urowitz, J. Sibley, 2006, Lupus.

The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients

D. Gladman, M. Urowitz, M. Urowitz, 2014, Lupus.

Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort

I. Bruce, D. Gladman, M. Urowitz, 2007, Lupus.

Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus

D. Gladman, M. Urowitz, P. Rahman, 2001, Lupus.

Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus

D. Gladman, M. Urowitz, P. Fortin, 2010, Arthritis care & research.

A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)

D. Gladman, M. Urowitz, M. Urowitz, 1996, Lupus.

SAT0404 Spot Urine Protein/Creatinine Ratio is Useful in Screening for Proteinuria but Should Not Substitute 24 hours Urine Collection Sample to Quantify Proteinuria in Lupus

M. Urowitz, D. Gladman, J. Su, 2015 .

SLEDAI-2K Responder Index 50 captures 50% improvement in disease activity over 10 years

M. Urowitz, D. Gladman, Z. Touma, 2012, Lupus.

SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation

M. Urowitz, D. Gladman, Z. Touma, 2011, Lupus.

Damage in lupus patients—what have we learned so far?

M. Urowitz, L. Eder, D. Gladman, 2013, Lupus.

Relationship between cardiac symptoms, myocardial perfusion defects and coronary angiography findings in systemic lupus erythematosus

D. Gladman, M. Urowitz, M. Urowitz, 2011, Lupus.

POS1153 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENTS FROM THE PUBLISHED LITERATURE

M. Urowitz, M. Dall'Era, A. Bomback, 2023, Annals of the Rheumatic Diseases.

Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus

D. Gladman, M. Urowitz, C. Gordon, 2014, Arthritis care & research.